Product logins

Find logins to all Clarivate products below.

home   •  Research Reports  •  Disease Landscape and Forecast Insights

Breast Cancer | Pharmacor | G7 | 2014

Login to access report north_east
Contact sales account_box

Last Updated 16 September 2014
Owing to its large population, the treatment of breast cancer remains an active area of research with a rich and diverse product pipeline. A competitive current therapies market means that barriers to entry are high, and relatively few of the many therapies in development will enter this lucrative market. Treatment is currently determined based on hormone-receptor and HER2 expression, and successful therapies are often those tailored to specific subpopulations.

Contact sales account_box
Login to access report north_east

Related Market Assessment Reports

Report
Breast Cancer – Geographic Focus: China – China In-Depth – Breast Cancer
The breast cancer therapy market in mainland China is one of the most dynamic in the oncology sector. Several new and emerging therapies are expected to gain approval for specific subpopulations,…
north_east
Report
Breast Cancer – Landscape & Forecast – Disease Landscape & Forecast (G7)
CDK4/6 inhibitors (Pfizer’s palbociclib, Novartis’s ribociclib, and Eli Lilly’s abemaciclib) combined with endocrine therapy are central to the treatment of metastatic HR-positive / HER2-…
north_east
Report
Breast Cancer – Unmet Need – Unmet Need – Metastatic Triple-Negative Breast Cancer (US/EU)
The treatment of metastatic triple-negative breast cancer is rapidly evolving with new combination therapies and biomarker-driven approaches. Immunotherapies such as Keytruda (Merck & Co.) have…
north_east
Report
Breast Cancer – Current Treatment – Current Treatment: Physician Insights – Breast Cancer (US)
The breast cancer treatment landscape is rapidly evolving. CDK4/6 inhibitors (Pfizer’s Ibrance, Novartis’s Kisqali, and Eli Lilly’s Verzenio) plus endocrine therapy are entrenched first-line…
north_east
Report
Breast Cancer – Current Treatment – Treatment Sequencing – Breast Cancer (US)
Key benefits and uses Pinpoint current drug positioning and uptake in one snapshot to facilitate forecasting. Drill down into physicians’ treatment sequences and understand whom to position…
north_east

Follow us

Contact us

Sales enquiries north_east
Customer service north_east
Support north_east